Cargando…

The Payer's Dilemma: Recognizing the Uncertainty of Clinical and Economic Evidence at Product Launch

Detalles Bibliográficos
Autores principales:	Watkins, John B., Sullivan, Sean D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2009
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438028/ https://www.ncbi.nlm.nih.gov/pubmed/19236133 http://dx.doi.org/10.18553/jmcp.2009.15.2.167

Ejemplares similares

Application of Economic Analyses in U.S. Managed Care Formulary Decisions: A Private Payer's Experience
por: Watkins, John B., et al.
Publicado: (2006)

Payer Perspectives on Health Technology Assessment
por: Watkins, John B.
Publicado: (2012)

Perspectives to mitigate payer uncertainty in health technology assessment of novel oncology drugs
por: Solà-Morales, Oriol, et al.
Publicado: (2019)

Payer perceptions on the use of economic models in oncology decision making
por: Biskupiak, Joseph, et al.
Publicado: (2021)

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
por: Sikirica, Mirko, et al.
Publicado: (2014)

Comparison of the clinical and economic outcomes between open and minimally invasive appendectomy and colectomy: evidence from a large commercial payer database
por: Fullum, Terrence M., et al.
Publicado: (2009)

Using Certification to Promote Uptake of Real-World Evidence by Payers
por: Segal, Jodi B., et al.
Publicado: (2016)

Trends in Oncology Clinical Trials Launched Before and During the COVID-19 Pandemic
por: Lamont, Elizabeth B., et al.
Publicado: (2021)

Dynaval: new product launch
Publicado: (2018)

Real-World Evidence: Bridging Gaps in Evidence to Guide Payer Decisions
por: Roberts, Melissa H., et al.
Publicado: (2020)

Trends in Payer Type for Emergency Department Visits in California, 2011-2019
por: Hsia, Renee Y., et al.
Publicado: (2023)

Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic
por: Kouzy, Ramez, et al.
Publicado: (2020)

Autoimmune Hepatitis or Wilson’s Disease, a Clinical Dilemma
por: Deutsch, Melanie, et al.
Publicado: (2013)

Economic policy uncertainty and energy production in China
por: Wei, Wei, et al.
Publicado: (2021)

Hospitals and the Tax-Payer
Publicado: (1920)

Comment on: The Effect of Intra-articular Hyaluronic Acid Injections and Payer Coverage on Total Knee Arthroplasty Procedures: Evidence From Large U.S. Claims Database
por: Molloy, Ilda B., et al.
Publicado: (2023)

The Role of Marketing in Launching New Products
por: Baker, Phil
Publicado: (2010)

Creating a Production Launch Plan
por: Warner, Alec
Publicado: (2020)

How to Launch Products in Uncertain Markets
por: Ross, Jan-Michael
Publicado: (2018)

Launching “Research Audit Units” to Curb Research Misconduct
por: Namazi, Mohammad Reza, et al.
Publicado: (2018)

Comment on: “Cost-Utility Analysis of Duloxetine in Osteoarthritis: A US Private Payer Perspective”
por: Liedgens, Hiltrud, et al.
Publicado: (2013)

US public and private payer coverage for tobacco cessation treatments and barriers to accessing treatments
por: Hussain, Radha, et al.
Publicado: (2022)

Uncertainty in techno-economic estimates of cellulosic ethanol production due to experimental measurement uncertainty
por: Vicari, Kristin J, et al.
Publicado: (2012)

The dilemma of xenotransplantation.
por: Chastel, C E
Publicado: (1996)

The Opiate Dilemma
por: Jeffrey, Paul L., et al.
Publicado: (2014)

Launched
Publicado: (1885)

Influence of uncertainty on framed decision-making with moral dilemma
por: Merlhiot, Gaëtan, et al.
Publicado: (2018)

A Private Payer Persective
por: Shurney, Dexter W.
Publicado: (2006)

Consolidation in the dental industry: a closer look at dental payers and providers
por: Nasseh, Kamyar, et al.
Publicado: (2019)

Economic burden of lung cancer in Turkey: a cost of illness study from payer perspective
por: Cicin, Irfan, et al.
Publicado: (2021)

Comment on: The Effect of Intra-articular Hyaluronic Acid Injections and Payer Coverage on Total Knee Arthroplasty Procedures: Evidence From Large US Claims Database
por: Pegreffi, Francesco, et al.
Publicado: (2023)

Healthcare Payer Perspectives on the Assessment and Pricing of Oncology Multi-Indication Products: Evidence from Nine OECD Countries
por: Mills, Mackenzie, et al.
Publicado: (2023)

Weathering Economic Shocks and Financial Uncertainty: Here We Go Again
por: Serido, Joyce
Publicado: (2020)

The impact of payer status on hospital admissions: evidence from an academic medical center
por: Zhao, Yanying, et al.
Publicado: (2021)

Payer perceptions of the use of real-world evidence in oncology-based decision making
por: Brixner, Diana, et al.
Publicado: (2021)

Listerial meningitis: A diagnostic dilemma
por: Jain, S, et al.
Publicado: (2019)

Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database
por: Pandya, Bhavik J., et al.
Publicado: (2020)

Advising Parents in the Face of Scientific Uncertainty: An Environmental Health Dilemma
por: Lubick, Naomi
Publicado: (2011)

Projected costs of single-payer healthcare financing in the United States: A systematic review of economic analyses
por: Cai, Christopher, et al.
Publicado: (2020)

Economic analysis of glucagon like peptide-1 receptor agonists from the Saudi Arabia payer perspective
por: Alkhatib, Nimer S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j0ne7i06udhv87icvsv09tb5tt